Cargando…
Decisional needs of patients with recurrent high-grade glioma and their families
BACKGROUND: High-grade gliomas are aggressive and life-threatening brain tumors. At the time of recurrence, the patients and their families need to decide on future treatment. None of the treatment options are curative, and tradeoffs between benefits and harms must be made. This study aimed to explo...
Autores principales: | Sorensen von Essen, Helle, Stacey, Dawn, Dahl Steffensen, Karina, Guldager, Rikke, Rom Poulsen, Frantz, Piil, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476966/ https://www.ncbi.nlm.nih.gov/pubmed/36127893 http://dx.doi.org/10.1093/nop/npac046 |
Ejemplares similares
-
Development of a Patient Decision Aid to Support Shared Decision Making for Patients with Recurrent High-Grade Glioma
por: Sorensen von Essen, Helle, et al.
Publicado: (2022) -
Shared decision making in high-grade glioma patients—a systematic review
por: Sorensen von Essen, Helle, et al.
Publicado: (2020) -
Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2020) -
Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype
por: Munthe, Sune, et al.
Publicado: (2016) -
Patient perspectives and experiences of the rapid implementation of digital consultations during COVID-19 — a qualitative study among women with gynecological cancer
por: Christiansen, Mille Guldager, et al.
Publicado: (2021)